Impact of modified Frailty Index-11 (mFI-11) on postoperative complications in patients undergoing transsphenoidal resection of pituitary tumors: Analysis of 2006–2014 ACS-NSQIP database

• Published in: Journal of clinical neuroscience Vol. 92; pp. 22 - 26
• Main Authors: Nguyen, Sarah, Kim, Robert B., Cox, Parker, Gamboa, Nicholas T., Karsy, Michael, Couldwell, William T., Menacho, Sarah T.
• Format: Journal Article
• Language: English
• Published: Elsevier Ltd 01.10.2021
• Subjects: Modified Frailty Index-11; Pituitary tumor; Postoperative complications; Transsphenoidal; Modified Frailty Index-11; Transsphenoidal; Pituitary tumor; Postoperative complications
• ISSN: 0967-5868; 1532-2653
• DOI: 10.1016/j.jocn.2021.07.046

•Frailty is a better predictor of physiologic reserve than age alone.•Increased frailty is associated with an increase in complications after many surgeries.•Frailty does not predict poorer postoperative outcomes following TSRPT. Frailty is a measure of physiologic reserve that is frequently cited as a predictor of postoperative complications. However, the effect of frailty on patients undergoing a relatively common procedure such as transsphenoidal resection of pituitary tumors (TSRPT) is unknown. Therefore, we sought to explore this relationship using a large, national database. The 2006–2014 American College of Surgeons National Surgical Quality Improvement Program database was retrospectively reviewed to identify all patients who underwent TSRPT. Frailty scores were assigned using the established 11-factor modified Frailty Index (mFI-11). Patients were divided into low-frailty and high-frailty groups, based on mFI comorbidities of ≤ 1 and ≥ 2, respectively. Univariable and multivariable analyses were performed to evaluate the impact of frailty on postoperative outcomes and mortality. A total of 993 patients were included in the analysis. The low-frailty group consisted of 825 patients; the high-frailty group comprised 168 patients. In univariable analysis, there were no significant differences in medical (low-frailty 4.8%, high-frailty 8.3%; p = 0.069) and surgical (low-frailty 1.1%, high-frailty 1.2%; p = 1.000) complications; however, the high-frailty group had a higher rate of mortality (3%) when compared with the low-frailty group (0.6%; p = 0.016, OR 4.07, p = 0.044) and longer hospitalization (4.5 ± 7.4 vs. 5.8 ± 6.8 days; p = 0.023). In multivariable analysis, frailty was a predictor of mortality but not complications or reoperation. Our study shows that frailty, as measured by the mFI-11, does not predict postoperative complications in patients who undergo TSRPT, but greater frailty is correlated with higher mortality and increased hospital length of stay.